Global Blood Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsGlobal Blood Therapeutics

Global Blood Therapeutics(GBT)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Oxbryta	Voxelotor	2019-11-25	2032-2037	Anemia , Sickle cell anemia , Hemolytic anemia

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

renal insufficiency

,

healthy volunteers/patients

,

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

chronic renal insufficiency

,

kidney diseases

,

sickle cell anemia

,

,

hypersensitivity

,

,

sickle cell anemia

,

healthy volunteers/patients

,

knee osteoarthritis

,

,

,

atrial fibrillation

,

venous thrombosis

,

venous thromboembolism

,

thromboembolism

,

,

chronic kidney failure

,

postmenopausal osteoporosis

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

pulmonary embolism

,

,

,

,

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

vascular calcification

,

cardiac surgical procedures

,

prediabetic state

,

diabetes mellitus

,

,

,

vitamin k deficiency

,

drug-related side effects and adverse reactions

,

heart valve diseases

,

metabolic bone diseases

,

medication adherence

,

,

,

hyperhomocysteinemia

,

intracranial hemorrhages

,

traumatic intracranial hemorrhage

,

chronic renal insufficiency

,

kidney diseases

,

cardiovascular diseases

,

,

,

,

,

,

atherosclerosis

,

,

potassium deficiency

,

,

oxidative stress

,

periodontal diseases

,

disease progression

,

,

,

,

,

cardiometabolic risk factors

,

cerebral hemorrhage

,

hypertensive intracranial hemorrhage

,

,

sickle cell anemia

,

healthy volunteers/patients

,

,

spine osteoarthritis

,

,

,

,

colonic neoplasms

,

myelodysplastic syndromes

,

disease progression

,

,

,

,

,

,

,

,

phobic disorders

,

respiratory tract infections

,

,

communicable diseases

,

multiple myeloma

,

plasma cell neoplasms

,

neoadjuvant therapy

,

rectal neoplasms

,

,

cardiovascular diseases

,

myocardial infarction

,

,

,

,

,

urinary bladder neoplasms

,

non-muscle invasive bladder neoplasms

,

streptococcal infections

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

tick-borne encephalitis

,

,

,

borrelia infections

,

,

,

migraine disorders

,

central serous chorioretinopathy

,

coronary artery bypass

,

unstable angina

,

cardiac arrhythmias

,

water-electrolyte balance

,

type 2 diabetes mellitus

,

,

insulin resistance

,

,

anxiety disorders

,

,

,

,

hydrophilic contact lenses

,

stomach neoplasms

,

peripheral nervous system diseases

,

,

,

mental health services

,

,

tooth discoloration

,

,

femoral neck fractures

,

,

retinal diseases

,

premature birth

,

retinopathy of prematurity

,

,

postoperative pain

,

,

,

puerperal disorders

,

gingival recession

,

attention deficit disorder with hyperactivity

,

,

,

,

,

,

wounds and injuries

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use